• Initial PNS contract commenced, additional 500 licenses to be deployed in Q1CY26
• Agreed metric for success is 3-5% savings, estimated up to US$88M per annum for PNS
• Significant discussions with key groups including PNS partners, U.S. healthcare organizations, and a Puerto Rican health fund

Singular Health Group Ltd reported a strong quarter of operational execution and commercial expansion, particularly in its U.S. market. The initial contract with Provider Network Solution (PNS) is progressing as per schedule, with 250 licenses of 3DICOM™ MD deployed during the quarter and a further 500 licenses scheduled for Q1CY26. The agreed metric for success is savings of 3-5%, which PNS estimates could result in cost savings of up to US$88M per annum. Early feedback from PNS has been very positive, exceeding expectations. In parallel, the company continues to advance significant discussions with other key groups, including direct partners of the PNS network, major U.S. healthcare organizations, a leading Puerto Rican health fund, and a U.S. university. The company also progressed engagement with U.S. federal government agencies to explore potential inclusion of 3DICOM™ in federal healthcare programs. During the quarter, the company established its wholly-owned U.S. subsidiary, Singular Health USA LLC, and appointed Paige Taylor as U.S. Chief Commercial Officer to lead the company's expansion in the American healthcare market. Technically, the company expanded its capabilities with the recruitment of additional senior software developers and the formation of Singular Health Pte Ltd in Singapore. The quarter also saw the launch of 3DICOM™ EDU, an enhanced online version of the R&D viewer for the education market.

The company expects to have more substantive data to determine the success of the PNS contract well before 30 June 2026, given the deployment of the second tranche of 500 licenses in Q1CY26 as per the contract milestones.

Supported by a strong cash position, positive engagement and progress from PNS, a strengthening pipeline of contracts, and expanding international, regulatory, and technical capabilities, the company is well placed to achieve sustainable growth and broad-scale adoption of 3DICOM™ in the U.S. and globally over the coming quarters.